MEI Pharma News

MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Wood Steven D

12minutes ago

MEI Pharma | 8-K: Current report

13:05 ET

MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Flynn James P

May 20 16:01 ET

MEI Pharma | 10-Q: Quarterly report

May 9 16:05 ET

MEI Pharma | 8-K: MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

May 9 16:03 ET

MEI Pharma | EFFECT: Others

Feb 29 06:08 ET

MEI Pharma | 424B5: Prospectus

Feb 28 16:10 ET

MEI Pharma | CORRESP: CORRESP

Feb 26 13:10 ET

MEI Pharma | UPLOAD: Others

Feb 23 13:09 ET

MEI Pharma | 8-K: Current report

Feb 21 16:02 ET

MEI Pharma | S-3: Registration statement for specified transactions by certain issuers

Feb 20 17:39 ET

MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(4.9%),Tang Capital Management, LLC(4.9%), etc.

Feb 14 16:03 ET

MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.85%)

Feb 13 22:44 ET

MEI Pharma | 8-K: MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Feb 13 18:06 ET

MEI Pharma | 10-Q: Quarterly report

Feb 13 17:10 ET

MEI Pharma | 8-K: Current report

Jan 17 00:00 ET

MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Flynn James P

Jan 12 00:00 ET

MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Wood Steven D

Jan 12 00:00 ET

MEI Pharma | 8-K: Current report

Dec 26, 2023 00:00 ET

MEI Pharma | 8-K: Current report

Dec 22, 2023 16:00 ET